Weili Xu

机构：Hebei Medical University, Second Hospital of Hebei Medical University · ORCID：0000-0001-6234-2805

发表论文 59 篇 · 总被引 240 次 · h-index 8

代表论文

• CD163 + Macrophages Induce Endothelial-to-Mesenchymal Transition in Atheroma (2024 · Circulation Research · 被引 49)
• Role of Thrombospondin-1 and Nuclear Factor-κB Signaling Pathways in Antiangiogenesis of Infantile Hemangioma (2018 · Plastic & Reconstructive Surgery · 被引 18)
• Clonal Proliferation Within Smooth Muscle Cells in Unstable Human Atherosclerotic Lesions (2023 · Arteriosclerosis Thrombosis and Vascular Biology · 被引 17)
• Targeted elimination of myeloid-derived suppressor cells via regulation of the STAT pathway alleviates tumor immunosuppression in neuroblastoma (2021 · Immunology Letters · 被引 14)
• Targeted inhibition of myeloid-derived suppressor cells in the tumor microenvironment by low-dose doxorubicin to improve immune efficacy in murine neuroblastoma (2020 · Chinese Medical Journal · 被引 9)
• The application effectiveness of an early enteral nutrition protocol constructed based on the enhanced recovery after surgery concept in ICU patients (2025 · Medicine · 被引 8)